Vision Researchers Query FDA About Updating Requirements For Drug Approval
Scientists and the Food and Drug Administration (FDA) are discussing how new technologies in ophthalmology, which make it possible to collect better data about experimental treatments, might affect FDA clinical trials requirements.
Read Full Article
Related Articles
- Assessment of macular retinal thickness and volume in normal eyes and highly myopic eyes with third-generation optical coherence tomography also categorized in Ophthalmology
- Medical Imaging Embedded Systems Expertise Expands, UK also published in Medical News Today
- Evaluation of peripapillary detachment in pathologic myopia with en face optical coherence tomography also categorized in Ophthalmology
- Change of foveal and perifoveal thickness measured by OCT after phacoemulsification and IOL implantation also categorized in Ophthalmology
- In vivo measurements of macular and nerve fibre layer thickness in retinal arterial occlusion also categorized in Ophthalmology
- Correlation between microaneurysm closure rate and reduction in macular thickness following laser photocoagulation of diabetic macular edema also categorized in Ophthalmology
- Optical coherence tomography on autologous translocation of choroid and retinal pigment epithelium in age-related macular degeneration also categorized in Ophthalmology
- Successful OCT Imaging Of Oral Cancer Tissue Announced By MDL And UCH, UK also published in Medical News Today
- Automatic retinal blood flow calculation using spectral domain optical coherence tomography also categorized in Ophthalmology
- Imalux Awarded $2.3 Million Research Grant also mentions National Institutes of Health
Login to comment.